Pieris Pharmaceuticals Inc (PIRS)
17.20
+0.33
(+1.96%)
USD |
NASDAQ |
Oct 31, 16:00
17.20
0.00 (0.00%)
After-Hours: 20:00
Pieris Pharmaceuticals Cash from Financing (Quarterly): 0.00 for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.00 |
| March 31, 2024 | |
| December 31, 2023 | 0.014M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 19.78M |
| March 31, 2023 | |
| December 31, 2022 | 0.093M |
| September 30, 2022 | 0.282M |
| June 30, 2022 | 0.281M |
| March 31, 2022 | 6.558M |
| December 31, 2021 | 4.901M |
| September 30, 2021 | 21.92M |
| June 30, 2021 | 22.62M |
| March 31, 2021 | 9.693M |
| December 31, 2020 | 0.075M |
| September 30, 2020 | 9.624M |
| June 30, 2020 | 0.416M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 31.66M |
| September 30, 2019 | 0.221M |
| June 30, 2019 | 0.28M |
| March 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2018 | 0.007M |
| September 30, 2018 | 0.276M |
| June 30, 2018 | 0.069M |
| March 31, 2018 | 48.16M |
| December 31, 2017 | 0.597M |
| September 30, 2017 | 2.028M |
| June 30, 2017 | 1.465M |
| March 31, 2017 | |
| December 31, 2016 | -0.00 |
| September 30, 2016 | -0.0597M |
| June 30, 2016 | 15.28M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.01M |
| September 30, 2015 | 25.78M |
| June 30, 2015 | -0.0434M |
| March 31, 2015 | -1.128M |
| September 30, 2014 | 0.003M |
| June 30, 2014 | 0.019M |
| March 31, 2014 | 0.0004M |
| December 31, 2013 | 0.0016M |
| September 30, 2013 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2020
31.66M
Maximum
Dec 2019
7.524M
Average
0.416M
Median
Jun 2020
Cash from Financing (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 9.491M |
| NovaBay Pharmaceuticals Inc | -0.492M |
| Palatin Technologies Inc | 5.991M |
| iBio Inc | 12.99M |
| Theriva Biologics Inc | 1.773M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.48M |
| Cash from Investing (Quarterly) | 2.176M |
| Free Cash Flow | -37.87M |
| Free Cash Flow Per Share (Quarterly) | -1.139 |
| Free Cash Flow Yield | -175.8% |